References
- 1. Salje H, Tran Kiem C, Lefrancq N, et al (2020). Estimating the burden of SARS-CoV-2 in France. Science. 369: 208–11. doi: 10.1126/science.abc3517.
- 2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 28; 395 (10229):1054–62. doi: 10.1016/S0140-6736(20)30566-3.
- 3. ABED, N. ., ZIBOUCHE, A. ., MEDJOUDJ, S. ., GOUMEIDANE, S. ., & ROUABAH, L. (2022). Biological characteristics and mortality in patients with diabetes and COVID-19. Notulae Scientia Biologicae, 14(3), 11276. https://doi.org/10.55779/nsb14311276.
- 4. Wu Z, Mc Googan JM (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA; 323:1239–42. doi:10.1001/jama.2020.2648.
- 5. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine; 8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5.
- 6. Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al (2020). Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 14238. doi: 10.1111/all.14238.
- 7. Magro C, Mulvey JJ, Berlin D, et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational Research; 220:1–3. doi: 10.1016/j.trsl.2020.04.007.
- 8. Tang, D Li, X Wang, Z Sun (2020). Abnormal coagulation parameters are associated with poorprognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 18(4), p. 844-847. doi: 10.1111/jth.14768.
- 9. Guan WJ 1, Liang WH, Zhao Y et al (2020). China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: A Nationwide Analysis. European Respiratory Journal. doi: 10.1183/13993003.00547-2020.
- 10. Wang D, Hu B, Hu C (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323(11):1061. doi:10.1001/jama.2020.1585.
- 11. Gao Y, Li T, Han M, et al. (2020). Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. Prelease from Journal of Medical Virology; 92:791–6. doi: 10.1002/jmv.25770.
- 12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet; 395 (10223):507–513. doi: 10.1016/S0140-6736(20)30211-7.
- 13. Guan WJ 2, Ni ZY, Hu Y, et al (2020). China medical treatment expert group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine; 382:1707–20. doi: 10.1056/NEJMoa2002032.
- 14. Luigi Palmieri, Xanthi Andrianou et al (2020). Characteristics of COVID-19 patients dying in Italy Report based on available data on March 20th. https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdf.
- 15. Levi M, J Thachil, T Iba, et J H Levy (2020). Coagulation abnormalities and thrombosis in patients with COVID-19, The Lancet Haematology., 7(6), p. e438,. doi: 10.1016/S2352-3026(20)30145-9.
- 16. Becker RC (2020). COVID-19 update: Covid-19-associated coagulopathy. Journal of Thrombosis and Thrombolysis. 50:54–67. https://doi.org/10.1007/s11239-020-02134-3.
- 17. Mitra S, Ling RR, Yang IX et al (2021) Severe COVID-19 and coagulopathy: a systematic review and meta-analysis. Annals of the Academy of Medicine of Singapore. 50(4):325–335. https://doi.org/10.47102/annalsacadmedsg.2020420.
- 18. Tan CW, Fan BE, Teo WZY et al (2021). Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore. Thrombosis Journal. 19:14. https://doi.org/10.1186/s12959-021-00268-9.
- 19. Fan BE, Ng J, Chan SSW et al (2021). COVID-19 associated coagulopathy in critically ill patients: a hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. Journal of Thrombosis and Thrombolysis. 51:663–674. https://doi.org/10.1007/s11239-020-02318-x.
- 20. Klok FA, Kruip MJHA, van der Meer NJM et al (2020). Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research. 191:145–147. https://doi.org/10.1016/j.thromres.
- 21. Fan B E, Ramanathan K, Sum C L L et al (2022). Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study. Journal of Thrombosis and Thrombolysis. 53:646–662. https://doi.org/10.1007/s11239-021-02575-4.